JUND and cancer: Increased AP-1 activity is observed during tumor growth; for example, overexpression of c-Fos and c-Jun in tumors is associated with cancer aggressiveness, and in chronic inflammation AP-1 stimulates cytokines and metalloproteinases [195,196].